CPS1 and metabolic dysfunction-associated steatotic liver disease: It is very interesting that low CPS1 expression and hyperammonemia have been measured in Non-Alcoholic Steato Hepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD), which are very common diseases worldwide.